KROS Competitors & Alternatives
Compare Keros Therapeutics Inc with similar stocks in the same industry
Biotechnology
KROS
Main Stock$11.35
Tradestie Score
58
Market Cap
$620.60M
Revenue Growth
-1.0%
Analyst Upside
+74.7%
Top Competitors
220 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
VOR
Vor Biopharma Inc. Common Stock
|
$18.94
|
$269.08M | 0.1 | 64 | Compare |
|
PBYI
PUMA BIOTECHNOLOGY INC
|
$11.26
|
$265.45M | 21.0 | 46 | Compare |
|
VTYX
Ventyx Biosciences, Inc. Common Stock
|
$14.00
|
$256.71M | - | 51 | Compare |
|
NGNE
Neurogene, Inc. Common Stock
|
$24.28
|
$256.54M | - | 53 | Compare |
|
SLN
Silence Therapeutics Plc American Depository Share
|
$19.66
|
$240.89M | - | 35 | Compare |
|
OABI
OmniAb, Inc. Common Stock
|
$4.78
|
$231.77M | - | 48 | Compare |
|
SGMT
Sagimet Biosciences Inc. Series A Common Stock
|
$9.95
|
$227.00M | - | 47 | Compare |
|
SLS
SELLAS Life Sciences Group, Inc. Common Stock
|
$11.35
|
$211.22M | - | 46 | Compare |
|
ACRS
Aclaris Therapeutics, Inc.
|
$3.83
|
$202.58M | - | 61 | Compare |
|
FBRX
Forte Biosciences, Inc. Common Stock
|
$76.99
|
$180.53M | - | 54 | Compare |
More KROS Analysis
Data updated: Oct 23, 2026 | Industry: Biotechnology (SIC 2834)
220 stocks in this industry